CO

Convexia

YC S25

San Francisco, US · Founded 2025 · 4 employees · 1 known investors

convexia.bio ↗

Convexia provides AI-powered drug discovery and evaluation software that scans global sources for overlooked drug assets and runs deep in silico simulations across 50+ models to assess binding, toxicity, pharmacokinetics, and immunogenicity. The platform combines AI agents with expert human review to accelerate drug asset evaluation for biotech companies, pharma firms, and venture investors.

Founders & leadership· Y Combinator alumni (S25)

AP

Ayaan ParikhinFounder

RV

Rahul VijayaninCo-Founder & CTO

Investors · 1

Y

Y CombinatorSan Francisco · $500K